Company / Operating Cash Flow per Share
PTC Therapeutics, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$9.15
FY2025
5-year range
-$2.74 / $9.15
FY2021-FY2025
Trend
+743.5%
vs FY2024
Sector context
#12 of 212
Health Care
What the data says
Operating Cash Flow per Share changed +743% YoY in FY2025, a notable deviation from the 9-year average annual change of +42%.
Based on SEC 10-K filings.
9.15 in FY2025. Top quartile in the Health Care sector.
Improved from $-2.17 to $9.15 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 212This company $9.15 Sector average $5.28
▼
+73.5% above sector average
Key checks
Key Insights
- PTC Therapeutics, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 743.5% year-over-year.
- Ranks #12 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.15 | +743.5% |
| FY2024 | -$1.42 | +34.4% |
| FY2023 | -$2.17 | +20.9% |
| FY2022 | -$2.74 | -93.7% |
| FY2021 | -$1.41 | -217.0% |
| FY2020 | -$0.45 | +73.4% |
| FY2019 | -$1.68 | -152.3% |
| FY2018 | -$0.66 | -125.5% |
| FY2017 | -$0.29 | +90.4% |
| FY2016 | -$3.05 | +19.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026